AG Ventures Q2 FY22 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what AG Ventures management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what AG Ventures management said on order book — free account, 30 seconds.
Capex plans
Track AG Ventures — get its next earnings analysis in your feed
How does AG Ventures rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does AG Ventures rank in Chemicals & Petrochemicals?
Compare AG Ventures against every Chemicals & Petrochemicals company (Q2 FY22) on revenue, margins and earnings-call signals.
Continue your research
What AG Ventures's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Sudarshan Chem. (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…